Janus Henderson Global Life Sciences Fund Class I (JFNIX)

Net Asset Value
1 Day
Overall Morningstar Rating
Style or Category
No Load
Sales Expenses
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. The fund pursues its investment objective by investing- under normal circumstances- at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio managers believe have a life science orientation. In the fund's pursuit of companies with a life science orientation- the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.


1 month+2.08% 3 years+2.34%
3 months+3.46% 5 years+16.91%
1 year+15.33% Since inception+18.80%
Data through --

Peer Comparisonvs. Health

Performance 5-yr return+16.91%+14.29%
Expense ratio0.77%1.29%
Risk 5 year sharpe ratio1.010.90
Net assets$3.7B$3.0B
Average market cap$18.1B$9.5B
Average P/E26.621.7
Portfolio turnover38%38%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyJanus Henderson
Fund manager & tenureAndrew Acker / 11 Years
Minimal initial investment$1,000,000.00
Minimum IRA investment--


U.S. stock78.18%
International stock17.20%
Fixed income2.53%
Top 5 Sectors
Portfolio weighting
Healthcare 94.74%
Consumer service 3.23%
Consumer goods 0.79%
Business service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
-- 3.42%
LLY Eli Lilly and Co2.69%
SHPG Shire2.66%
-- 2.62%
HUM Humana Inc2.42%
BSX Boston Scientific Corp2.28%
CELG Celgene2.24%
NKTR Nektar Therapeutics2.19%
ANTM WellPoint2.09%
BIIB Biogen2.08%